Morteza Hemmat

Director, Clinical Cytogenetics at Quest Diagnostics - Secaucus, New Jersey, US

Morteza Hemmat's Colleagues at Quest Diagnostics
Lisa Tay

Certified Phlebotomist

Contact Lisa Tay

Antonio Perez

Group Lead CLS III (CGMBS)

Contact Antonio Perez

Ahmad Shalhout

Sr. Technical Specialist

Contact Ahmad Shalhout

Mayar Daya

Drug Monitoring & Toxicology - Account Executive Northern Cal/Reno

Contact Mayar Daya

Amanda Kohanchi

Bioanalytical Report and Biomarker Quality Improvement Specialist

Contact Amanda Kohanchi

View All Morteza Hemmat's Colleagues
Morteza Hemmat's Contact Details
HQ
(973) 520-2700
Location
Irvine, California
Company
Quest Diagnostics
Morteza Hemmat's Company Details
Quest Diagnostics logo, Quest Diagnostics contact details

Quest Diagnostics

Secaucus, New Jersey, US • 28469 Employees
Hospital/Clinic

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2020 revenues of $9.44 billion. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients. Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals. More information is available at www.questdiagnostics.com. Language Assistance / Non-Discrimination Notice Asistencia de Idiomas / Aviso de no Discriminación 語言協助 / 不歧視通知 www.QuestDiagnostics.com/home/nondiscrimination

Clinical Laboratories Medical Diagnostics Laboratory Testing Patient Care Healthcare Management Drug Development And Manufacturing Rapid Diagnostic Testing Anatomic Pathology
Details about Quest Diagnostics
Frequently Asked Questions about Morteza Hemmat
Morteza Hemmat currently works for Quest Diagnostics.
Morteza Hemmat's role at Quest Diagnostics is Director, Clinical Cytogenetics.
Morteza Hemmat's email address is ***@questdiagnostics.com. To view Morteza Hemmat's full email address, please signup to ConnectPlex.
Morteza Hemmat works in the Hospital/Clinic industry.
Morteza Hemmat's colleagues at Quest Diagnostics are Lisa Tay, Diala Dahabreh, Antonio Perez, Scott Tharpe, Ahmad Shalhout, Mayar Daya, Amanda Kohanchi and others.
Morteza Hemmat's phone number is (973) 520-2700
See more information about Morteza Hemmat